์๋ฏธ์ฝ์๋ธ
์๋ฏธ์ฝ์๋ธ๋ COX-2 ํจ์์ ๋ํด ๋์ ์ ํ์ฑ์ ๊ฐ์ง๋ ์ฝ์๋ธ ๊ณ์ด์ ๋น์คํ ๋ก์ด๋์ฑ ํญ์ผ์ฆ์ (NSAID)์ ๋๋ค. ์์ํ์์๋ ์ฃผ๋ก ๋ฐ๋ ค๊ฒฌ์ ๊ณจ๊ด์ ์ผ๊ณผ ๊ด๋ จ๋ ํต์ฆ ๋ฐ ์ผ์ฆ ์ํ, ๊ทธ๋ฆฌ๊ณ ์ ํ์ธ๊ณผ ๋๋ ์ฐ๋ถ์กฐ์ง ์์ ๋ก ์ธํ ์์ ์ ํ ํต์ฆ ๊ด๋ฆฌ์ ์ฌ์ฉ๋ฉ๋๋ค. > **๊ฒฝ๊ณ :** ๋ชจ๋ NSAID์ ๋ง์ฐฌ๊ฐ์ง๋ก ์์ฅ๊ด, ์ ์ฅ ๋ฐ ๊ฐ ๋ถ์์ฉ์ ์ํ์ด ์์ต๋๋ค. **์์ ํ:** ์๋ฏธ์ฝ์๋ธ๋ ๋ณต์ฝ ์์๋๋ฅผ ๋์ด๊ธฐ ์ํด ๊ธฐํธ์ฑ์ด ์ข์ ์ธ์ด๋ธ ์ ์ ๋ก ์ ์กฐ๋์์ผ๋, ์ฐ๋ฐ์ ์ธ ๋๋ ๊ณผ๋ค ๋ณต์ฉ์ ๋ฐฉ์งํ๊ธฐ ์ํด ๋ฐ๋ ค๋๋ฌผ์ ์์ด ๋ฟ์ง ์๋ ๊ณณ์ ์๊ฒฉํ ๋ณด๊ดํด์ผ ํฉ๋๋ค.
์์ฉ ๊ธฐ์ : Cimicoxib **selectively inhibits the cyclooxygenase-2 (COX-2) enzyme**. โ This limits the conversion of arachidonic acid to **prostaglandins** (such as PGE2) that mediate pain, inflammation, and fever. โ By sparing the COX-1 enzyme at therapeutic doses, it aims to maintain normal physiological functions like gastric mucosal protection and renal blood flow, though selectivity is not absolute and adverse effects can still occur.
๋๋ฌผ ์ข ๋ณ ์ฉ๋
- Osteoarthritis and perioperative pain due to orthopaedic or soft tissue surgery ยท Not specified in text ยท PO ยท Not specified ยท 3-7 days ยท Dose not explicitly stated in the provided snippet. Formulations available are 8 mg, 30 mg, and 80 mg.
์ฉ๋์ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์ฐธ๊ณ ์๋ฃ์ ๋๋ค. ํญ์ ์ต์ ๋ผ๋ฒจ๊ณผ ๊ฐ๋ณ ํ์์ ๋ํด ํ์ธํ์ญ์์ค.
ํฌ์ฌ ๊ฒฝ๋ก
๊ธ๊ธฐ
- Dogs less than 10 weeks of age
- Dogs weighing less than 2 kg
- Gastrointestinal disorders or ulceration
- Impaired hepatic, cardiac, or renal function
- Bleeding disorders
- Pregnancy and lactation
- Hypersensitivity to NSAIDs or sulfonamides
์ด์๋ฐ์
- Vomiting
- Diarrhea
- Anorexia
- Gastrointestinal ulceration
- Elevated liver enzymes
- Renal impairment
- Lethargy
์ฝ๋ฌผ ์ํธ์์ฉ
- Corticosteroids ยท Increased risk of severe gastrointestinal ulceration and bleeding ยท major
- Other NSAIDs ยท Increased risk of gastrointestinal and renal toxicity ยท major
- ACE inhibitors ยท Increased risk of nephrotoxicity and reduced hypotensive effect ยท moderate
- Diuretics ยท Increased risk of nephrotoxicity ยท moderate
- Warfarin ยท Competition for plasma protein binding sites, potentially increasing bleeding risk ยท moderate
๋ชจ๋ํฐ๋ง
- Renal function (BUN, Creatinine, SDMA, Urinalysis)
- Hepatic function (ALT, ALP, Bilirubin)
- Clinical signs of GI upset (vomiting, diarrhea, melena)
- Hydration status
๊ณผ์ฉ๋
Overdose may lead to severe gastrointestinal signs (vomiting, bloody diarrhea, ulceration), renal failure, and hepatic damage. > **Treatment:** Discontinue the drug immediately. Initiate supportive care including intravenous fluid therapy to support renal perfusion, gastroprotectants (e.g., omeprazole, sucralfate), and closely monitor renal and hepatic blood parameters.
VetSheet ์ฝ๋ฌผ ๋ ํผ๋ฐ์ค๋ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์์ฌ๊ฒฐ์ ๋ณด์กฐ ๋๊ตฌ์ด๋ฉฐ, ์ ๋ฌธ์ ํ๋จ์ด๋ ์ ์กฐ์ฌ์ ์ต์ ๋ผ๋ฒจ์ ๋์ ํ์ง ์์ต๋๋ค.